Related Experiment Video
Updated: May 27, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Many stimuli pull the necrotic trigger, an overview
N Vanlangenakker1, T Vanden Berghe, P Vandenabeele
1Department for Molecular Biomedical Research, VIB, Zwijnaarde-Ghent, Belgium.
Abstract:
The lab of Jürg Tschopp was the first to report on the crucial role of receptor-interacting protein kinase 1 (RIPK1) in caspase-independent cell death. Because of this pioneer finding, regulated necrosis and in particular RIPK1/RIPK3 kinase-mediated necrosis, referred to as necroptosis, has become an intensively studied form of regulated cell death. Although necrosis was identified initially as a backup cell death program when apoptosis is blocked, it is now recognized as a cellular defense mechanism against viral infections and as being critically involved in ischemia-reperfusion damage. The observation that RIPK3 ablation rescues embryonic lethality in mice deficient in caspase-8 or Fas-associated-protein-via-a-death-domain demonstrates the crucial role of this apoptotic platform in the negative control of necroptosis during development. Here, we review and discuss commonalities and differences of the increasing list of inducers of regulated necrosis ranging from cytokines, pathogen-associated molecular patterns, to several forms of physicochemical cellular stress. Since the discovery of the crucial role of RIPK1 and RIPK3 in necroptosis, these kinases have become potential therapeutic targets. The availability of new pharmacological inhibitors and transgenic models will allow us to further document the important role of this form of cell death in degenerative, inflammatory and infectious diseases.
Insights
Regulated necrosis, particularly necroptosis mediated by RIPK1/RIPK3 kinases, is a critical cellular defense. This review explores necroptosis inducers and its role in disease, highlighting RIPK1/RIPK3 as therapeutic targets.
Area of Science:
- Cell Biology
- Immunology
- Molecular Medicine
Background:
- Receptor-interacting protein kinase 1 (RIPK1) is crucial in caspase-independent cell death.
- Regulated necrosis, especially RIPK1/RIPK3 kinase-mediated necroptosis, is a key cellular defense and implicated in disease.
- Necroptosis acts as a backup to apoptosis and plays roles in viral defense and ischemia-reperfusion injury.
Purpose of the Study:
- To review and discuss inducers of regulated necrosis.
- To highlight the role of RIPK1 and RIPK3 in necroptosis.
- To explore the therapeutic potential of targeting necroptosis.
Main Methods:
- Literature review of regulated necrosis research.
- Discussion of RIPK1 and RIPK3 roles in cell death pathways.
- Analysis of RIPK3's role in controlling necroptosis during development.
Main Results:
- RIPK1 is essential for caspase-independent cell death.
- RIPK3 ablation rescues lethality in mice lacking apoptosis components, indicating its role in negative control of necroptosis.
- Various inducers, including cytokines and cellular stress, trigger regulated necrosis.
Conclusions:
- RIPK1 and RIPK3 are central to necroptosis, a significant regulated cell death pathway.
- Necroptosis is involved in viral infections, inflammatory diseases, and ischemia-reperfusion damage.
- RIPK1 and RIPK3 are promising therapeutic targets for treating various diseases.
Related Concept Videos
Cellular Injury IV: Necrosis
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Inflammation
Chronic Inflammation: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...